The Food and Drug Administration said Friday it approved a new blood cancer drug from Onyx Pharmaceuticals Inc. for patients with advanced disease who have not responded to at least two other drugs
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment